Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatologic changes after systemic cancer therapy.

D W Nixon, D Pirozzi, R M York

    Cutis
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Combined yeast and microalgal cultivation in a pilot-scale raceway pond for urban wastewater treatment and potential biodiesel production.

    Water science and technology : a journal of the International Association on Water Pollution Research·2018
    Same author

    Detecting adverse drug reactions - a concise updateI. Cohort and case control studies.

    The International journal of risk & safety in medicine·2013
    Same author

    Acetylator phenotype and the clinical pharmacology of slow-release procainamide.

    British journal of clinical pharmacology·2012
    Same author

    ENT specific guidance for deep venous thrombosis prophylaxis.

    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2008
    Same author

    Thyroid surgery: the sub-mental drain.

    The Journal of laryngology and otology·2008
    Same author

    Obstetric outcomes subsequent to intrauterine death in the first pregnancy.

    BJOG : an international journal of obstetrics and gynaecology·2007

    Systemic cancer therapy often causes common dermatologic changes, including cytotoxic effects, pigment alterations, and rashes. Recognizing these skin manifestations can help clinicians avoid unnecessary diagnostic tests.

    Area of Science:

    • Oncology
    • Dermatology
    • Cancer Therapeutics

    Background:

    • Systemic cancer therapies frequently induce dermatologic side effects.
    • These cutaneous changes can impact patient quality of life and treatment adherence.
    • Understanding these adverse events is crucial for comprehensive cancer care.

    Purpose of the Study:

    • To categorize and describe common dermatologic changes associated with systemic cancer therapy.
    • To provide clinicians with a framework for identifying and managing these side effects.
    • To emphasize the importance of recognizing these manifestations to prevent unnecessary investigations.

    Main Methods:

    • Review of clinical presentations of skin changes in patients undergoing cancer treatment.
    • Categorization of observed dermatologic effects into distinct clinical groups.

    Related Experiment Videos

  • Clinical observation and literature synthesis.

    • Main Results:

    • Dermatologic changes are a common occurrence in patients receiving systemic cancer therapy.
    • These changes can be broadly classified into three main categories: cytotoxic effects, pigment alterations, and rashes/eruptions.
    • Identification of specific patterns within each category.

    Conclusions:

    • Clinicians should be aware of the spectrum of potential skin reactions to systemic cancer therapies.
    • Prompt recognition of these dermatologic manifestations can aid in appropriate patient management.
    • Alertness to these side effects can help avoid unnecessary diagnostic work-ups and associated healthcare costs.